Market Research Report
GlaxoSmithKline Plc in Consumer Health (World)
|Published by||Euromonitor International||Product code||973045|
|Published||Content info||38 Pages
Delivery time: 1-2 business days
|GlaxoSmithKline Plc in Consumer Health (World)|
|Published: November 19, 2020||Content info: 38 Pages||
GSK maintained its market-leading position in 2020, on the back of its merger with Pfizer. While Advil sales faltered, Panadol and Centrum buoyed the company's growth globally in 2020 and Voltaren's Rx-to-OTC switch benefited the US. Emergen-C was the star performer amidst the Coronavirus pandemic. Exploring growth opportunities in China and other emerging markets will enable stronger growth in the future. Increasing foothold in the areas of immunity and holistic health will also support growth.
Euromonitor International's GlaxoSmithKline Plc in Consumer Health (World) Company Profile offers detailed strategic analysis of the company's business, examining its performance in the Consumer Health industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
State of Play
Exposure to Future Growth
Vitamins and Dietary Supplements
Cough, Cold and Allergy (Hay Fever) Remedies